NicoDerm® CQ® and Nicorette®:

Proven Smoking-Cessation Products

Nicorette Gum

Nicorette® Gum

Doubles smoking-cessation rates in highly dependent smokers.1*†‡  Only Nicorette® Gum has patented dual-coated technology.

Abstinence rates 2X higher than placebo

  •  The use of 4-mg nicotine gum more than tripled quit rates versus placebo at 30 days among patients with a history of treatment failure
  •  TTFC is an appropriate measure of dependence among smokers
Dosing Information and How to Use Nicorette Gum

Dosing Information and
How to Use

Advise patients to read and follow label directions. Behavioral support may increase their chances of success.

Dosing Information and How to Use a

 

More than 2x higher chances of quitting at 12 weeks

 

Learn about Nicorette® Lozenge and Nicorette® mini® Lozengea

* Abstinence rates with Nicorette® Gum were statistically significantly different from placebo at Plinear trend=0.02.

Highly dependent smokers have their first cigarette within 30 minutes of waking up.

A secondary analysis of a large, randomized, placebo-controlled trial that included subjects (N=608) who were ≥20 years of age, smoked ≥5 cigarettes per day, and were in good overall health. Subjects were randomly assigned to placebo or 2-mg or 4-mg nicotine gum and were instructed to quit smoking. Participants had brief (5- to 10-minute) individual smoking-cessation counseling sessions at each study visit, beginning with the quit day. Abstinence status was self-reported and biochemically verified at 9 time points: days 1, 7, 14, and 30; months 2, 3, 6, and 19; and 1 year.

References:

1. Shiffman S, Sembower MA, Rohay JM, Gitchell JG, Garvey AJ. Assigning dose of nicotine gum by time to first cigarette. Nicotine Tob Res. 2013;15(2):407-412.